Only in Titles

           Search results for: Recombinant Human BMP-2, Monomer Proteins    

paperclip

#22691543   2012/07/23 Save this To Up

Codon optimization for high level expression of human bone morphogenetic protein-2 in Escherichia coli.

Codons in the open reading frame (ORF) encoding for human bone morphogenetic protein-2 (hBMP-2) were optimized to reach high level expression in Escherichia coli. The optimization was done by the computer programs DNA works and DNA Star according to Thermodynamically Balanced Inside Out (TBIO) approach. The ORF consisting of 342 base pairs (bp) was assembled using two-steps Polymerase Chain Reaction, cloned into a pGEM-T vector with a mutation rate of 6.38 bp per kb and transformed into E. coli JM109. After a DNA sequence confirmation, mutation-free ORF was subcloned into pET32b and transformed into E. coli BL21(DE3). The rhBMP-2 was produced as a thioredoxin-his-tag fusion protein at relatively high level, approximately 60% of total intracellular proteins as inclusion bodies (IB), with a yield of 1.39 g per liter culture. Solubilization of IB gave soluble monomer rhBMP-2 with a recovery of 13.6% and refolding of soluble rhBMP-2 produced dimeric forms with a yield of 8.7%. The size and identity of the purified rhBMP-2 was confirmed by nano-LC-MS/MS2 analysis. Our work demonstrates for the first time that by using TBIO approach, a codon-optimized ORF encoding for rhBMP-2 protein can be expressed at high level in E. coli expression system.

2281 related Products with: Codon optimization for high level expression of human bone morphogenetic protein-2 in Escherichia coli.

Bone Morphogenetic Protei Human Bone Morphogenetic Recombinant Mn SOD (Human Bone Morphogenetic Protei Bone Morphogenetic Protei Bone Morphogenetic Protei Bone Morphogenetic Protei Bone Morphogenetic Protei Growth Differentiation Fa Human Macrophage Inflamma Human Macrophage Inflamma Human Gro g Macrophage In

Related Pathways

paperclip

#16298141   2006/04/03 Save this To Up

Expression, purification, and renaturation of bone morphogenetic protein-2 from Escherichia coli.

Homodimeric bone morphogenetic protein-2 (BMP-2) is a member of the transforming growth factor beta superfamily that has been used for bone grafting. We were interested in exploring the functions of BMP-2 in other disease areas and focused on expressing and purifying active BMP-2 proteins. We have developed a new approach which involves using FoldIt refolding buffer to refold BMP-2 followed by a heparin affinity column to separate correctly folded dimer from monomer. A high yield of 29.4 mg BMP-2 dimer per gram cell wet weight was achieved. The purified BMP-2 dimer was shown to possess the same level of activity as BMP-2 from CHO cells as tested by the induction of alkaline phosphatase activity in C2C12 cells. This approach has potential application in refolding and purifying other homodimeric proteins.

2963 related Products with: Expression, purification, and renaturation of bone morphogenetic protein-2 from Escherichia coli.

Bone Morphogenetic Protei Human Bone Morphogenetic Polyclonal Antibody Bone Recombinant Mn SOD (Human E.coli RecA Protein E.coli RecA Protein E.col E.coli RuvA Protein E.coli RuvA Protein E.col E.coli RuvB Protein E.coli RuvB Protein E.col E.coli RuvC Protein E.coli RuvC Protein E.col

Related Pathways

paperclip

#11432587   2001/07/02 Save this To Up

Release of recombinant human bone morphogenetic protein-2 from heterocyclic methacrylate polymer systems.

The release of recombinant human bone morphogenetic protein-2 (rhBMP-2) from three room temperature polymerising methacrylate systems has been studied. These all contained poly(ethyl methacrylate) powder, but the monomer liquids comprised, respectively, tetrahydrofurfuryl methacrylate (THFM), 90/10 THFM/hydroxyethyl methacrylate (HEMA), and 70/30 THFM/ HEMA. In all cases, rhBMP-2 was released, but the addition of 10% HEMA accelerated release (a nine-fold increase in diffusion coefficient); a further increase to 30% HEMA had no additional effect. For most of the release process, a diffusion process operated, although the early stages were not well defined. At the end of the 15 day period, the release, respectively, for the PEM/THFM, PEM:90/10 THFM/HEMA and PEM:70/30 THFM/HEMA systems was 596, 878 and 923 ng (i.e. up to 92% of the rhBMP-2 added).

2180 related Products with: Release of recombinant human bone morphogenetic protein-2 from heterocyclic methacrylate polymer systems.

Bone Morphogenetic Protei Bone Morphogenetic Protei Bone Morphogenetic Protei Bone Morphogenetic Protei Bone Morphogenetic Protei Bone Morphogenetic Protei Human Bone Morphogenetic Heat Shock Protein 20, hu Heat Shock Protein 22, hu Heat Shock Protein 27, hu Heat Shock Protein 90, hu Heat Shock Protein 70, hu

Related Pathways